Serodiagnosis of Zika virus (ZIKV) infections by a novel NS1-based ELISA devoid of cross-reactivity with dengue virus antibodies: a multicohort study of assay performance, 2015 to 2016.

PubWeight™: 0.94‹?›

🔗 View Article (PMID 28006649)

Published in Euro Surveill on December 15, 2016

Authors

Katja Steinhagen1, Christian Probst1, Christiane Radzimski1, Jonas Schmidt-Chanasit2,3, Petra Emmerich2, Marjan van Esbroeck4, Janke Schinkel5, Martin P Grobusch6,7, Abraham Goorhuis6, Jens M Warnecke1, Erik Lattwein1, Lars Komorowski1, Andrea Deerberg1, Sandra Saschenbrecker1, Winfried Stöcker1, Wolfgang Schlumberger1

Author Affiliations

1: Institute for Experimental Immunology, EUROIMMUN AG, Lübeck, Germany.
2: WHO Collaborating Centre for Arbovirus and Haemorrhagic Fever Reference and Research, Bernhard-Nocht Institute for Tropical Medicine, Hamburg, Germany.
3: German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel, Hamburg, Germany.
4: National Reference Center for Arboviruses, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
5: Department of Medical Microbiology, Section of Clinical Virology, Academic Medical Center, Public Health Service, Amsterdam, the Netherlands.
6: Center for Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
7: Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany.

Articles cited by this

Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med (2009) 17.89

Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis (2008) 12.72

Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet (2016) 10.08

Zika Virus Associated with Microcephaly. N Engl J Med (2016) 9.03

Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis (1997) 5.13

Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J Clin Microbiol (2002) 4.63

Molecular biology of flaviviruses. Adv Virus Res (2003) 4.39

Zika Virus in the Americas--Yet Another Arbovirus Threat. N Engl J Med (2016) 3.78

Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication. Virology (1996) 3.60

Detection of Zika virus in urine. Emerg Infect Dis (2015) 3.52

Pathogenic flaviviruses. Lancet (2008) 3.34

Notes from the Field: Evidence of Zika Virus Infection in Brain and Placental Tissues from Two Congenitally Infected Newborns and Two Fetal Losses - Brazil, 2015. MMWR Morb Mortal Wkly Rep (2016) 3.05

Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylation-dependent fashion. J Virol (1999) 2.07

STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ (2015) 1.99

Evidence that the mature form of the flavivirus nonstructural protein NS1 is a dimer. Virology (1988) 1.70

The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker. Antiviral Res (2013) 1.67

Zika and the Risk of Microcephaly. N Engl J Med (2016) 1.52

High specificity of a novel Zika virus ELISA in European patients after exposure to different flaviviruses. Euro Surveill (2016) 1.37

Zika Virus and Microcephaly. N Engl J Med (2016) 1.36

Comparison of Test Results for Zika Virus RNA in Urine, Serum, and Saliva Specimens from Persons with Travel-Associated Zika Virus Disease - Florida, 2016. MMWR Morb Mortal Wkly Rep (2016) 1.28

False positive dengue NS1 antigen test in a traveller with an acute Zika virus infection imported into Switzerland. Swiss Med Wkly (2016) 1.23

NS1 protein secretion during the acute phase of West Nile virus infection. J Virol (2005) 1.22

Specific IgM and IgG responses in primary and secondary dengue virus infections determined by enzyme-linked immunosorbent assay. Epidemiol Infect (2005) 1.21

How malaria modulates memory: activation and dysregulation of B cells in Plasmodium infection. Trends Parasitol (2013) 1.07

Correlation between dengue-specific neutralizing antibodies and serum avidity in primary and secondary dengue virus 3 natural infections in humans. PLoS Negl Trop Dis (2013) 1.03

Preexisting neutralizing antibody responses distinguish clinically inapparent and apparent dengue virus infections in a Sri Lankan pediatric cohort. J Infect Dis (2014) 0.94

The synthesis and maturation of a non-structural extracellular antigen from tick-borne encephalitis virus and its relationship to the intracellular NS1 protein. J Gen Virol (1989) 0.91

Longitudinal follow-up of Zika virus RNA in semen of a traveller returning from Barbados to the Netherlands with Zika virus disease, March 2016. Euro Surveill (2016) 0.91

Extended surface for membrane association in Zika virus NS1 structure. Nat Struct Mol Biol (2016) 0.87

Spot the difference-development of a syndrome based protein microarray for specific serological detection of multiple flavivirus infections in travelers. PLoS Negl Trop Dis (2015) 0.82

Letter to the editor: Specificity of Zika virus ELISA: interference with malaria. Euro Surveill (2016) 0.80

Specificity of Dengue NS1 Antigen in Differential Diagnosis of Dengue and Zika Virus Infection. Emerg Infect Dis (2016) 0.78